The Metabolic Syndrome Network: Physiology, Pharmacology, and Practice

This accredited CE activity examines metabolic syndrome as a set of interrelated physiological processes — adipose tissue dysfunction, insulin resistance, atherogenic dyslipidemia, and chronic inflammation — rather than a collection of separate diagnoses. The shared mechanisms connecting these processes to downstream conditions including hypertension, type 2 diabetes, atherosclerotic cardiovascular disease, and chronic kidney disease are reviewed. This activity also covers the pharmacologic classes used to address these mechanisms, limitations in current clinical trial evidence for patients with overlapping conditions, and the role of lifestyle intervention alongside pharmacotherapy.

Target Audience

This activity is designed for an interprofessional audience involved in the care of patients with metabolic syndrome and its related conditions, including physicians, nurse practitioners, physician assistants, pharmacists, registered nurses and registered dietitians.

Learning Objectives

Summarize how adipose tissue dysfunction, insulin resistance, atherogenic dyslipidemia, and chronic inflammation contribute to metabolic syndrome and how individuals differ.
Outline how major drug classes act on factors contributing to metabolic syndrome and their shared molecular pathways.
Identify adverse effects and monitoring considerations for patients being treated for metabolic syndrome, including areas of scientific uncertainty.
Describe the limitations of current evidence for patients with overlapping metabolic, cardiovascular, and renal conditions, and the practical factors shaping treatment access.
Identify the overlap between lifestyle intervention and pharmacotherapy, and the shared knowledge base supporting interprofessional care.

Commercial Support

There is no commercial support.

Course summary

Available credit:

1.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners^® (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and . AKH Inc., Advancing Knowledge in Healthcare is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.00 contact hour(s) (which includes 1.00 hour(s) of pharmacology).
- 1.00 AANP Pharmacology Contact Hours
1.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
1.00 ACPE Pharmacist
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours.
1.00 ACPE Pharmacy Technician
Pharmacy Technicians
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours.
1.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.00 ANCC Contact Hours
Nurses
Credit being awarded: 1.00 ANCC contact hours
1.00 CDR
Dietitians
1.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.

Course opens:

10/09/2026

Course expires:

10/09/2028

Cost:

$19.95

Rating:

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)